BIOA CIK: 1709941

BioAge Labs, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
−37.4
FY24:
−51.5
FY25:
−81.6
Change from FY22 to FY25
millions USD
FY22:
−0.10
FY23:
−0.27
FY24:
−0.37
FY25:
−95.2
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
34.9
FY24:
381
FY25:
11.5
millions USD
FY22:
–
FY23:
−2.69
FY24:
329
FY25:
−165
(positive)
Change from FY22 to FY25
millions USD
FY22:
−36.3
FY23:
−37.5
FY24:
−51.9
FY25:
−82.3

All amounts in millions USD FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data